We are live on ! Find out more
NEPH icon

Nephros
NEPH

17 hedge funds and large institutions have $14.9M invested in Nephros in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

6% less funds holding

Funds holding: 18 → 17 (-1)

36.48% less ownership

Funds ownership: 53.12% → 16.64% (-36%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

72% less capital invested

Capital invested by funds: $53.8M → $14.9M (-$38.8M)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CPA
Cowen Prime Advisors
New York
+$292K
2
Morgan Stanley
Morgan Stanley
New York
+$78.1K
3
BA
Bard Associates
Illinois
+$23.4K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$14.6K
5
SC
Samjo Capital
New York
+$7.8K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$46.8K
2
Millennium Management
Millennium Management
New York
-$13.9K
3
TRCT
Tower Research Capital (TRC)
New York
-$3K
4
UBS Group
UBS Group
Switzerland
-$139
5
Wells Fargo
Wells Fargo
California
-$43
Name Holding Trade Value Shares
Change 		Change in
Stake
CPA
1
Cowen Prime Advisors
New York
$5.79M +$292K +33,700 +5%
SC
2
Samjo Capital
New York
$4.82M +$7.8K +900 +0.2%
BA
3
Bard Associates
Illinois
$2.05M +$23.4K +2,700 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$891K +$14.6K +1,682 +2%
HighTower Advisors
5
HighTower Advisors
Illinois
$488K – – –
William Blair & Company
6
William Blair & Company
Illinois
$318K – – –
BlackRock
7
BlackRock
New York
$158K -$46.8K -5,395 -23%
Morgan Stanley
8
Morgan Stanley
New York
$121K +$78.1K +9,004 +186%
Millennium Management
9
Millennium Management
New York
$118K -$13.9K -1,599 -11%
EP
10
Elkhorn Partners
Nebraska
$75K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$40K – – –
SIC
12
Salem Investment Counselors
North Carolina
$31K – – –
TCWM
13
Total Clarity Wealth Management
Illinois
$6K +$5.66K +653 New
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1K +$789 +91 New
Bank of America
15
Bank of America
North Carolina
$1K +$945 +109 +182%
TRCT
16
Tower Research Capital (TRC)
New York
– -$3K -350 Closed
UBS Group
17
UBS Group
Switzerland
– -$139 -16 -59%
Wells Fargo
18
Wells Fargo
California
– -$43 -5 -9%

NEPH Hedge Fund Activity: Q3 2021 in Review

17 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2021, worth a combined $14.9M — down 72% from $53.8M a quarter earlier.

Fund positioning in NEPH was balanced in Q3 2021: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 4 trimmed.

The largest buyer was Cowen Prime Advisors, adding an estimated $292K. The largest seller was BlackRock, cutting an estimated $46.8K.

  • 17 institutional investors held Nephros (NEPH) as of Q3 2021, down from 18 in Q2 2021.
  • Funds reported $14.9M of Nephros stock for Q3 2021, down 72% quarter-over-quarter.
  • 2 funds opened new Nephros positions in Q3 2021 and 2 closed out, a net change of 0 holders.
  • The largest Nephros buyer in Q3 2021 was Cowen Prime Advisors, an estimated $292K added.
  • The largest Nephros seller in Q3 2021 was BlackRock, an estimated $46.8K sold.

Based on aggregated 13F filings for Q3 2021.